BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15684613)

  • 21. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
    Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation.
    Kobuchi H; Moriya K; Ogino T; Fujita H; Inoue K; Shuin T; Yasuda T; Utsumi K; Utsumi T
    PLoS One; 2012; 7(11):e50082. PubMed ID: 23189181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs.
    Tamura A; Onishi Y; An R; Koshiba S; Wakabayashi K; Hoshijima K; Priebe W; Yoshida T; Kometani S; Matsubara T; Mikuriya K; Ishikawa T
    Drug Metab Pharmacokinet; 2007 Dec; 22(6):428-40. PubMed ID: 18159130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure.
    Robey RW; Shukla S; Steadman K; Obrzut T; Finley EM; Ambudkar SV; Bates SE
    Mol Cancer Ther; 2007 Jun; 6(6):1877-85. PubMed ID: 17575116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
    Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
    Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.
    Ogino T; Kobuchi H; Munetomo K; Fujita H; Yamamoto M; Utsumi T; Inoue K; Shuin T; Sasaki J; Inoue M; Utsumi K
    Mol Cell Biochem; 2011 Dec; 358(1-2):297-307. PubMed ID: 21748335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Cisplatin-Derived Increase of Mitochondrial Reactive Oxygen Species Enhances the Effectiveness of Photodynamic Therapy via Transporter Regulation.
    Kurokawa H; Ito H; Matsui H
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells.
    Susanto J; Lin YH; Chen YN; Shen CR; Yan YT; Tsai ST; Chen CH; Shen CN
    PLoS One; 2008; 3(12):e4023. PubMed ID: 19107196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
    Usuda J; Tsunoda Y; Ichinose S; Ishizumi T; Ohtani K; Maehara S; Ono S; Tsutsui H; Ohira T; Okunaka T; Furukawa K; Sugimoto Y; Kato H; Ikeda N
    Lung Cancer; 2010 Feb; 67(2):198-204. PubMed ID: 19477032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New inhibitors of ABCG2 identified by high-throughput screening.
    Henrich CJ; Robey RW; Bokesch HR; Bates SE; Shukla S; Ambudkar SV; Dean M; McMahon JB
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3271-8. PubMed ID: 18089721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
    Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
    Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
    Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced efficacy of photodynamic therapy by inhibiting ABCG2 in colon cancers.
    Kim JH; Park JM; Roh YJ; Kim IW; Hasan T; Choi MG
    BMC Cancer; 2015 Jul; 15():504. PubMed ID: 26149077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of ABCG2 by MYBL2 deletion drives Chlorin e6-mediated photodynamic therapy resistance in colorectal cancer.
    Hui YJ; Chen H; Peng XC; Li LG; Di MJ; Liu H; Hu XH; Yang Y; Zhao KL; Li TF; Yu TT; Wang WX
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103558. PubMed ID: 37030434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy with 5-aminolaevulinic acid and DNA damage: unravelling roles of p53 and ABCG2.
    Postiglione I; Barra F; Aloj SM; Palumbo G
    Cell Prolif; 2016 Aug; 49(4):523-38. PubMed ID: 27389299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.
    Robey RW; Obrzut T; Shukla S; Polgar O; Macalou S; Bahr JC; Di Pietro A; Ambudkar SV; Bates SE
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):575-83. PubMed ID: 19132374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The livestock photosensitizer, phytoporphyrin (phylloerythrin), is a substrate of the ATP-binding cassette transporter ABCG2.
    Robey RW; Fetsch PA; Polgar O; Dean M; Bates SE
    Res Vet Sci; 2006 Dec; 81(3):345-9. PubMed ID: 16808938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.